Industry-Focused Panel Discussion
Time: 5:00 pm
day: Day One
During development of new immuno-modulatory therapeutics, when is the best time to evaluate cytokine release?
- As a stand-alone assay comparing molecules in a side-by-side assay for lead
- During analysis of preclinical efficacy as part of the overall mode of action
- Later stage, post preclinical efficacy to determine safety/tox prior to IND filing.